{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T08:53:07Z","timestamp":1769935987236,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ajog.2013.10.010","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T07:57:23Z","timestamp":1381391843000},"page":"302-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers"],"prefix":"10.1016","volume":"210","author":[{"given":"Hendr\u00e9e E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisanna","family":"Deppen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Hudak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Leffert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelyn","family":"Starer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishka","family":"Terplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John M.","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea A.","family":"Creanga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2013.10.010_bib1","first-page":"2","article-title":"Maternal opium habit and infant mortality","volume":"III","author":"Earle","year":"1888","journal-title":"Med Standard"},{"key":"10.1016\/j.ajog.2013.10.010_bib2","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2013.10.010_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1081\/ADA-120018838","article-title":"Effectiveness of substance abuse treatment programming for women: a review","volume":"29","author":"Ashley","year":"2003","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.ajog.2013.10.010_bib4","series-title":"Substance abuse treatment: addressing the specific needs of women: treatment improvement protocol (TIP) series 51; vol HHS publication no. (SMA) 09-4426","year":"2009"},{"key":"10.1016\/j.ajog.2013.10.010_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0163278704267037","article-title":"The effects of physician empathy on patient satisfaction and compliance","volume":"27","author":"Kim","year":"2004","journal-title":"Eval Health Prof"},{"key":"10.1016\/j.ajog.2013.10.010_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1001\/jama.1996.03540060072041","article-title":"Breaking bad news: a review of the literature","volume":"276","author":"Ptacek","year":"1996","journal-title":"JAMA"},{"issue":"suppl","key":"10.1016\/j.ajog.2013.10.010_bib7","first-page":"S9","article-title":"Empathy and quality of care","volume":"52","author":"Mercer","year":"2002","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ajog.2013.10.010_bib8","first-page":"796","article-title":"The impact of patient-centered care on outcomes","volume":"49","author":"Stewart","year":"2000","journal-title":"J\u00a0Fam Pract"},{"key":"10.1016\/j.ajog.2013.10.010_bib9","first-page":"1423","article-title":"Effective physician-patient communication and health outcomes: a review","volume":"152","author":"Stewart","year":"1995","journal-title":"CMAJ"},{"key":"10.1016\/j.ajog.2013.10.010_bib10","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.5858\/2008-132-1617-SLEAQA","article-title":"Specimen labeling errors: a Q-probes analysis of 147 clinical laboratories","volume":"132","author":"Wagar","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajog.2013.10.010_bib11","series-title":"Pain management testing reference","author":"White","year":"2007"},{"key":"10.1016\/j.ajog.2013.10.010_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/00952998609007394","article-title":"Pregnancy in a drug-abusing population","volume":"12","author":"Fitzsimmons","year":"1986","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.ajog.2013.10.010_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jsat.2007.10.007","article-title":"Treatment of opioid-dependent pregnant women: clinical and research issues","volume":"35","author":"Jones","year":"2008","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"suppl 1","key":"10.1016\/j.ajog.2013.10.010_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.ajog.2013.10.010_bib15","unstructured":"Food and Drug Administration. Guidance for\u00a0Industry Providing Clinical Evidence of Effectiveness for Human Drugs and Biological Products. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), May 1998, Clinical 6."},{"issue":"suppl 1","key":"10.1016\/j.ajog.2013.10.010_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1360-0443.2012.04036.x","article-title":"Maternal opioid treatment: human experimental research (MOTHER): approach, issues, and lessons learned","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.ajog.2013.10.010_bib17","first-page":"61","article-title":"A\u00a0comparison of buprenorphine\u00a0+ naloxone to buprenorphine and methadone in the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes","volume":"7","author":"Lund","year":"2013","journal-title":"Subst Abuse"},{"key":"10.1016\/j.ajog.2013.10.010_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.drugalcdep.2010.01.004","article-title":"Infant autonomic functioning and neonatal abstinence syndrome","volume":"109","author":"Jansson","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"suppl 1","key":"10.1016\/j.ajog.2013.10.010_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1360-0443.2012.04037.x","article-title":"Fetal assessment before and after dosing with buprenorphine or methadone","volume":"107","author":"Salisbury","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.ajog.2013.10.010_bib20","doi-asserted-by":"crossref","first-page":"11526","DOI":"10.1016\/0002-9378(73)90953-8","article-title":"Narcotic withdrawal in pregnancy: stillbirth incidence with a case report","volume":"116","author":"Rementeria","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.10.010_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9378(75)90613-4","article-title":"Fetal stress from methadone withdrawal","volume":"122","author":"Zuspan","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.10.010_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/10550490802266276","article-title":"Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes","volume":"17","author":"Jones","year":"2008","journal-title":"Am J Addict"},{"key":"10.1016\/j.ajog.2013.10.010_bib23","first-page":"854","article-title":"Opioid detoxification in pregnancy","volume":"92","author":"Dashe","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.10.010_bib24","unstructured":"Health Insurance Portability and Accountability Act of 1996 (HIPAA). Pub. L. 104-191, 110 Stat. 1936, enacted Aug. 21, 1996."},{"key":"10.1016\/j.ajog.2013.10.010_bib25","series-title":"Pharmacological therapies for drug and alcohol addictions","first-page":"373","article-title":"Pharmacological therapies of pain in drug and alcohol addictions","author":"Savage","year":"1995"},{"key":"10.1016\/j.ajog.2013.10.010_bib26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0310057X0403200406","article-title":"Challenges that opioid-dependent women present to the obstetric anaesthetist","volume":"32","author":"Cassidy","year":"2004","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.ajog.2013.10.010_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.7326\/0003-4819-144-2-200601170-00010","article-title":"Acute pain management for patients receiving maintenance methadone or buprenorphine therapy","volume":"144","author":"Alford","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2013.10.010_bib28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejpain.2010.03.002","article-title":"Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy","volume":"14","author":"Meyer","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.ajog.2013.10.010_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.AOG.0000275288.47258.e0","article-title":"Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy","volume":"110","author":"Meyer","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.10.010_bib30","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.lpm.2012.04.011","article-title":"[When and how to detoxify clients from methadone maintenance treatment?]","volume":"42","author":"Ksouda","year":"2013","journal-title":"Presse Med"},{"key":"10.1016\/j.ajog.2013.10.010_bib31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/GRF.0b013e31816fea3d","article-title":"Pregnancy and alcohol use: evidence and recommendations for prenatal care","volume":"51","author":"Bailey","year":"2008","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.10.010_bib32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0889-8545(03)00082-2","article-title":"Screening and prevention of alcohol and drug use disorders in women","volume":"30","author":"Svikis","year":"2003","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajog.2013.10.010_bib33","first-page":"756","article-title":"A\u00a0survey of obstetrician-gynecologists on their patients' alcohol use during pregnancy","volume":"95","author":"Diekman","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.10.010_bib34","first-page":"36","article-title":"Gender differences in provider's use of a standardized screening tool for prenatal substance use","volume":"5","author":"Oser","year":"2011","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.ajog.2013.10.010_bib35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0002-9378(89)90302-5","article-title":"The T-ACE questions: practical prenatal detection of risk-drinking","volume":"160","author":"Sokol","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2013.10.010_bib36","first-page":"55","article-title":"New assessment tools for risk drinking during pregnancy: T-ACE, TWEAK, and others","volume":"18","author":"Russell","year":"1994","journal-title":"Alcohol Health Res World"},{"key":"10.1016\/j.ajog.2013.10.010_bib37","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/sj.jp.7211823","article-title":"Validation of the 4P's plus screen\u00a0for substance use in pregnancy validation of the 4P's plus","volume":"27","author":"Chasnoff","year":"2007","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.ajog.2013.10.010_bib38","series-title":"CSAP special report 13: maternal substance use assessment methods reference manual: a\u00a0review of screening and clinical assessment instruments for examining maternal use of alcohol, tobacco, and other drugs","year":"1993"},{"key":"10.1016\/j.ajog.2013.10.010_bib39","unstructured":"Center for Substance Abuse Treatment. Buprenorphine. Available at: http:\/\/buprenorphine.samhsa.gov\/index.html Accessed Sept. 30,\u00a02013."},{"key":"10.1016\/j.ajog.2013.10.010_bib40","unstructured":"American Psychiatric Association. PCSS-B Training: an education resource for those treating patients with opioid use disorders. HOT\u00a0TOPICS in buprenorphine treatment webinars. Available at: http:\/\/psychiatry.org\/pcssbwebinars. Accessed Sept. 30,\u00a02013."},{"key":"10.1016\/j.ajog.2013.10.010_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.drugalcdep.2013.02.031","article-title":"Induction of pregnant women onto opioid-agonist maintenance medication: An analysis of withdrawal symptoms and study retention","volume":"132","author":"Holbrook","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajog.2013.10.010_bib42","unstructured":"Jones HE. Inducting and stabilizing opioid-dependent pregnant women on methadone or\u00a0buprenorphine: current research and future\u00a0treatment implications 2010. Available at: http:\/\/psychiatry.org\/practice\/professional-interests\/addiction-psychiatry\/inducting-and-stabilizing-opioid-dependent-pregnant-women-on-methadone-or-buprenorphine-current-research-and-future-treatment-implications. Accessed Sept. 30,\u00a02013."},{"key":"10.1016\/j.ajog.2013.10.010_bib43","unstructured":"Meyer MC. Buprenorphine treatment during pregnancy 2012. Available at: http:\/\/psychiatry.org\/practice\/professional-interests\/addiction-psychiatry\/Buprenorphine-Treatment-During-Pregnancy. Accessed Sept. 30,\u00a02013."},{"key":"10.1016\/j.ajog.2013.10.010_bib44","series-title":"Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction: treatment improvement protocol (TIP) series 40. DHHS Publication No. (SMA) 04-3939","year":"2004"},{"key":"10.1016\/j.ajog.2013.10.010_bib45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1360-0443.1988.tb03981.x","article-title":"Assessment of opioid dependence with naloxone","volume":"83","author":"Peachey","year":"1988","journal-title":"Br J Addict"},{"key":"10.1016\/j.ajog.2013.10.010_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J\u00a0Psychoactive Drugs"},{"key":"10.1016\/j.ajog.2013.10.010_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","article-title":"Two new rating scales for opiate withdrawal","volume":"13","author":"Handelsman","year":"1987","journal-title":"Am J Drug Alcohol Abuse"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813010582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937813010582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:57:02Z","timestamp":1757588222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937813010582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0002937813010582"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2013.10.010","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2013.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}